ArticleNorthern clinics of Istanbul2026
Changes in pharmacological management of low back pain: Real-world evidence from a 4-year comparison (2021-2025).
Article in Northern clinics of Istanbul, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveContemporary guidelines recommend conservative, non-pharmacological management as first-line treatment for low back pain (LBP), yet real-world implementation remains variable. Understanding temporal trends in prescribing patterns is essential for evaluating alignment with evidence-based recommendations. The purpose of this study was to evaluate changes in pharmacological and non-pharmacological treatment strategies for LBP in a tertiary physical medicine and rehabilitation (PMR) outpatient clinic by comparing 2 time periods 4 years apart.
methodsThis retrospective observational study reviewed medical records of consecutive adult patients (≥18 years) presenting with LBP during October-November 2021 (n=252) and October-November 2025 (n=267) at a tertiary PMR center. Treatment strategies were categorized as non-steroidal anti-inflammatory drugs (NSAIDs) alone, muscle relaxants alone, combination therapy (NSAID+muscle relaxant), or non-pharmacological management only. Statistical comparisons were performed using Chi-square tests and odds ratios (ORs) with 95% confidence intervals (CIs).
resultsOverall pharmacological prescribing decreased significantly from 51.6% (130/252) in 2021 to 36.3% (97/267) in 2025 (OR: 0.54, 95% CI: 0.38-0.77, p=0.001). NSAID prescribing declined from 25.4% to 13.5% (p=0.001), whereas non-pharmacological management increased from 48.4% to 63.7% (p=0.001). The shift toward conservative management was most pronounced in patients aged ≥65 years, with pharmacological prescribing decreasing from 58.3% to 36.5% (OR: 0.41, 95% CI: 0.22-0.77, p=0.005).
conclusionTreatment strategies for LBP in a tertiary PMR setting appeared to reflect greater alignment with contemporary guideline recommendations over the 4-year study period. These findings may reflect increasing alignment with contemporary evidence-based recommendations emphasizing non-pharmacological approaches and reduced pharmacological exposure, particularly in older adults at higher risk of medication-related adverse events.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.